Research ArticlePulmonary fibrosis

Caveolin-1–derived peptide limits development of pulmonary fibrosis

See allHide authors and affiliations

Science Translational Medicine  11 Dec 2019:
Vol. 11, Issue 522, eaat2848
DOI: 10.1126/scitranslmed.aat2848

Article Information

vol. 11 no. 522

PubMed: 
Print ISSN: 
Online ISSN: 
History: 
  • Received for publication February 10, 2018
  • Resubmitted March 5, 2019
  • Accepted for publication November 8, 2019
  • .

Author Information

  1. Amarnath Satheesh Marudamuthu1,*,
  2. Yashodhar Prabhakar Bhandary1,*,
  3. Liang Fan1,*,
  4. Vijay Radhakrishnan1,
  5. BreAnne MacKenzie2,
  6. Esther Maier3,
  7. Shwetha Kumari Shetty1,
  8. M.R. Nagaraja1,
  9. Venkadesaperumal Gopu1,
  10. Nivedita Tiwari1,
  11. Yajie Zhang3,
  12. Alan B. Watts3,
  13. Robert O. Williams III3,
  14. Gerald J Criner4,
  15. Sudhir Bolla4,
  16. Nathaniel Marchetti4,
  17. Steven Idell1 and
  18. Sreerama Shetty1,
  1. 1Department of Medicine, Texas Lung Injury Institute, University of Texas Health Science Center at Tyler, 11937 US Highway 271, Tyler, TX 75708, USA.
  2. 2Lung Therapeutics Inc., 2801 Via Fortuna Suite 425 Austin, TX 78746, USA.
  3. 3Division of Molecular Pharmaceutics and Drug Delivery, College of Pharmacy, University of Texas at Austin, 2409 University Avenue, Austin, TX 78712, USA.
  4. 4Department of Thoracic Medicine and Surgery, Lewis Katz School of Medicine, Temple University, 3401 North Broad Street, Philadelphia, PA 19140, USA.
  1. Corresponding author. Email: sreerama.shetty{at}uthct.edu
  • * These authors contributed equally to this work.

Altmetric

Article usage

Article usage: December 2019 to February 2020

AbstractFullPdf
Dec 20192564523424
Jan 202025214296
Feb 20201113034

Stay Connected to Science Translational Medicine